CSL - Selling And Administration Expenses

Stock Price
140.66
Daily Change
-0.37 -0.26%
Monthly
-7.19%
Yearly
-43.25%
Q1 Forecast
138.07

CSL reported $1.23B in Selling and Administration Expenses for its fiscal semester ending in December of 2025.





Selling And Administration Expenses Change Date
Alterity Therapeutics Limited AUD 2.29M 649.1K Jun/2023
Arca Biopharma USD 5.16M 346K Mar/2025
aTyr Pharma USD 4.8M 130K Sep/2025
Bio Path USD 1.26M 456K Mar/2025
Brainstorm Cell Therapeutics USD 1.78M 319K Mar/2025
Cara Therapeutics USD 4.64M 2.19M Mar/2025
CSL USD 1.23B 498M Dec/2025
Curis USD 4.79M 100K Jun/2024
Esperion Therapeutics USD 39.98M 4.21M Sep/2024
Immunic USD -0.24 0.03 Sep/2024
Infinity Pharmaceuticals USD 3.75M 2.19M Jun/2023
Minerva Neurosciences USD 2.48M 58.79K Sep/2024
Sangamo BioSciences USD 9.64M 1.83M Jun/2024
TherapeuticsMD USD 1.23M 90K Jun/2024